Radicle Relaxation 24: A Study of Health and Wellness Products on Stress and Related Health Outcomes

Stress Clinical Trial

Official title: Radicle Relaxation™ 24: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Stress and Related Health Outcomes

Status Active, not recruiting

Clinical Trial Summary

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on stress and related health outcomes

Clinical Trial Description

This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) endorse a desire for less stress (2) have the opportunity for meaningful improvement (at least 20%) in their primary health outcome, and (3) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants over 7 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study. ;

Related Conditions & MeSH terms

• Stress

• NCT number: NCT06378801
• Study type: Interventional
• Source: Radicle Science
• Status: Active, not recruiting
• Phase: N/A
• Start date: February 29, 2024
• Completion date: August 2024